✦ LIBER ✦

Combined Lamivudine and Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Recurrence after Liver Transplantation: Long-Term Results

✍ Scribed by Jérôme Dumortier; Philippe Chevallier; Jean-Yves Scoazec; Françoise Berger; Olivier Boillot

Book ID: 114423647
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 61 KB
Volume: 3
Category: Article
ISSN: 1600-6135
DOI: 10.1034/j.1600-6143.2003.00191.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of hepatitis B recurrence aft

Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis

✍ Shusen Zheng; Yaomin Chen; Tingbo Liang; Anwei Lu; Weilin Wang; Yan Shen; Min Zh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

The aim of our study was to determine the outcomes of liver transplant recipients receiving either lamivudine (LAM) monotherapy or LAM combined with low-dose intramuscular (IM) hepatitis B Immunoglobulin (HBIG) therapy. We performed a retrospective review of the medical records of patients that had

Randomized trial of lamivudine versus he

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation

✍ Nikolai V Naoumov; A.Ross Lopes; Patrizia Burra; Lucio Caccamo; Rosa M Iemmolo; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Hepatitis B immunoglobulins and/or lamiv

Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: A systematic review

✍ Jie Chen; Liping Yi; Ji Dong Jia; Hong Ma; Hong You 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Prophylaxis of hepatitis B recurrence af

Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin

✍ S Engler; P Sauer; E Klar; W Stremmel; B Kallinowski 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Long-term outcome of patients with lamiv

Long-term outcome of patients with lamivudine after early cessation of hepatitis B immunoglobulin for prevention of recurrent hepatitis B following liver transplantation

✍ M. Yuefeng; F. Weili; T. Wenxiang; X. Ligang; L. Guiling; G. Hongwei; L. Wencai; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Long-Term Results of Hepatitis B Immunog

Long-Term Results of Hepatitis B Immunoglobulin and Lamuvidine for Hepatitis B Prophylaxis After Liver Transplantation

✍ S. Sevmis; S. Aktas; H.H. Zia; A. Atiq; E. Akbas; H. Selcuk; H. Karakayali; M. H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 104 KB